Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Marie_Noir
    Junior Member
    • Jul 2011
    • 8

    #1

    Variants outside genes

    Dear all,

    not sure if this is the best fitting place for my question, but since it arose during bioinformatic analysis of my NGS data, I will post it here.

    I realized that although I have data from EXOME sequencing (enrichment with a standard kit from, I have to look it up, either Agilent or Nimblegen), I encountered lots of variants OUT OF known genes (as mapped onto NCBI genes, build 37). I know, that enrichtment is not 100% perfect, but I want to know what percentage of "extragenic" enrichtment is "normal"? I would be happy to hear about your experiences.

    Thanks in advance!
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    Originally posted by Marie_Noir View Post
    Dear all,

    not sure if this is the best fitting place for my question, but since it arose during bioinformatic analysis of my NGS data, I will post it here.

    I realized that although I have data from EXOME sequencing (enrichment with a standard kit from, I have to look it up, either Agilent or Nimblegen), I encountered lots of variants OUT OF known genes (as mapped onto NCBI genes, build 37). I know, that enrichtment is not 100% perfect, but I want to know what percentage of "extragenic" enrichtment is "normal"? I would be happy to hear about your experiences.

    Thanks in advance!
    The companies making the kits usually promise about 60% on target. Once I got 70%. So yeah, expect a lot of off target reads.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...